A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension

Author： Schachar Ronald A.   Raber Susan   Courtney Rachel   Zhang Min  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.36, Iss.9, 2011-09, pp. : 809-817

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Response of Retrobulbar Vasculature to Hypercapnia in Primary Open-Angle Glaucoma and Ocular Hypertension

By  

Ophthalmic Research, Vol. 39, Iss. 2, 2007-02 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Reduced plasma cortisol binding to albumin in ocular hypertension and primary open-angle glaucoma

By McCarty George R.   Schwartz Bernard  

Current Eye Research, Vol. 18, Iss. 6, 1999-06 ,pp. : 467-476

Informa Healthcare

Access to resources Recommend Favorite

Scleral Expansion Band Procedure: Therapy for Ocular Hypertension and Primary Open-angle Glaucoma

By Schachar Ronald A.  

Annals of Ophthalmology, Vol. 32, Iss. 2, 2000-06 ,pp. : 87-89

Humana Press, Inc

Access to resources Recommend Favorite

Health- and Vision-Related Quality of Life in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma

By  

Ophthalmologica, Vol. 229, Iss. 4, 2013-04 ,pp. : 227-234

Karger

Access to resources Recommend Favorite

Circadian Intraocular Pressure Control with Dorzolamide versus Timolol Maleate Add-On Treatments in Primary Open-Angle Glaucoma Patients Using Latanoprost

By  

Ophthalmic Research, Vol. 39, Iss. 1, 2006-12 ,pp. : 24-31

Karger

Access to resources Recommend Favorite